Verismo Therapeutics
verismotherapeutics.com
Oncology Therapeutics
Regenerative Medicine
Cell & Gene Therapy
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$63.2M
3 rounds on record
Latest round
$28M
Venture round · Apr 2026 · 6 mo ago
Team
201-500
employees, estimated range
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 21
Raised a round Venture round $28M · SEC Form D
Jul 7, 2023
Raised a round Venture round $19.2M · SEC Form D
Apr 26, 2021
Raised a round Venture round $16M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2026 | $28M | — | SEC Form D |
| Venture round | Jul 2023 | $19.2M | — | SEC Form D |
| Venture round | Apr 2021 | $16M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Verismo Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Gene KimExecutive OfficerSEC Form D
Bryan KimExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Building programmable in vivo immune-cell therapies across oncology and autoimmune disease.
Our CELLfinity platform is delivering safe in vivo cell & gene therapies that is based on our proprietary EXiVO approach, without…
The Next Generation in. OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid…
The future of targeted therapies. The Extroducer® is a novel, modality-agnostic endovascular infusion catheter with the ability to delivery…
Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies…
Overview
A paradigm-shifting technology featuring KIR-based CAR construct that has been proven to reduce T cell exhaustion & kill solid tumor models in in vivo studies.
People
Gene Kim
Executive Officer
Bryan Kim
Executive Officer, Director
Yang Jin
Director
Jong Yoon
Director
Dong Kim
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Philadelphia
United States
HQ
Whether you want to join our team, learn more about our science, or inquire about trials, we want to hear from you.
200-500 est. staff
3675 Market Street, Suite 200, Philadelphia, PA 19104